Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from SCRIP

15:05 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "SCRIP" found in our extensive news archives from over 250 global news sources.

More Information about SCRIP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SCRIP for you to read. Along with our medical data and news we also list SCRIP Clinical Trials, which are updated daily. BioPortfolio also has a large database of SCRIP Companies for you to search.

Showing News Articles 1–25 of 3,100+ from SCRIP

Thursday 20th September 2018

Novo Nordisk CSO Says R&D Revamp Reflects New Stem Cell And AI Focus

Mads Krogsgaard Thomsen tells Scrip that recent successes in stem cell research and the on-going advances in artificial intelligence helped...   

Phase III Roxadustat ALPS Data Positive For New Class Of Anemia Therapies

Positive top-line data from the ALPS study confirms the efficacy and safety of roxadustat, a Phase III-stage product which could...   

Spanish Biotechs Prepare To Seek Partners In Seville

Start-ups in Spain will descend on the Andalusian city next week for the BioSpain meeting in search of national and...    

Wednesday 19th September 2018

Sea & Ski, Back On Sunscreen Scene, Slapped By Rival Who Never Left

Sea & Ski’s infrared protection claims read as a bold attempt for competitive leverage after its disappearance from the market...    

NAD: Sea & Ski Sunscreens May Go ‘Beyond UV,’ But Not To Infrared Zone

Cross Brands Manufacturing’s stingily hand-picked in vitro test results for Sea & Ski sunscreens do not demonstrate a clear, consumer-relevant...   

Novartis Diabetes Triple Drug Combination Deemed 'Irrational' In India

Novartis’s plans for triple drug diabetes combination which includes vildagliptin have been turned down in India at least for now...   

Some Double Bar-Coding Required After November DSCSA Deadline, US FDA Says

As agency offers further guidance on how and when to begin complying with Drug Supply Chain Security Act requirements, one...   

Patient Experience Data: US FDA’s Evidentiary Standards Should Reflect Intended Use

Degree of rigor may vary depending upon intended use of the data throughout a drug’s lifecycle, stakeholders say in comments...   

DTC Ad Price Disclosure Provision Stripped From US Funding Bill

Even though measure was blocked in Congress, it may still advance through regulation.   

Galera Raises $150m To Take Lead Drug From Phase III To NDA Submission

Galera garnered $70m in Series C venture capital and $80m through a royalty deal tied to GC4419 and a follow-up...    

Will CBO Score CREATE Momentum For Generic Bill's Passage?

Strong savings estimate – and brand pharma's need to have pay-fors for its own legislative priorities – could finally get bill allowing generic...   

Will CBO Score CREATE(S) Momentum For Generic Bill's Passage?

Strong savings estimate – and brand pharma's need to have pay-fors for its own legislative priorities – could finally get bill allowing generic...   

Kratom Industry GMPs Target Swaying FDA By Exceeding Agency Standards

“We want to show that the kratom industry is maturing, that people want to do the right thing,” says AKA...    

Health, Beauty And Wellness Regulatory News: Warnings, Alerts, Recalls

Fourth recall of homeopathics linked to contaminated water; FDA posts alerts about Texas coop's products; and warnings note drug claims...   

Clovis, CEO Mahaffy Settle SEC Investor Fraud Charges Over Rociletinib Efficacy Claims

Clovis, CEO Patrick Mahaffy and former CFO Erie Mast will pay more than $20m to settle charges by the SEC...    

Phase III Data Put Zealand's Dasiglucagon On Track, But Behind Others, For Hypoglycemia Rescue

Zealand Pharma stresses fast onset of dasiglucagon, which it plans to file on its own but develop commercially through partnership.   

Payment 'Sunshine' Requirements Would Expand For Industry Under Senate-Passed Opioid Bill

A provision to expand Sunshine Act industry reporting requirements for companies in the Senate-passed “Opioid Crisis Response Act” has caught...   &

FDA OTC Switch Guidance Omits Some Turns As Approval Roadmap, CHPA Says

In its comment on draft guidance, OTC industry trade group urges US FDA to issue final guidance on "Innovative Approaches...   

Opioid Indications Under TGA Scrutiny As Australia Tackles Growing Misuse

The Australian drug regulator is reviewing the indications, pack sizes and information documents for consumers of potent opioid products to...   

Novo Nordisk CEO Says Group Doubling Medical Supplies in UK Ahead Of Brexit

Novo Nordisk's chief says the Danish company is stockpiling medicines in case of "no deal" hard Brexit   

Tuesday 18th September 2018

Spectrum To Test Poziotinib's Potential As First Line Treatment Of Exon 20 Mutant NSCLC

Spectrum is expanding a clinical trial with its novel, oral pan-HER inhibitor poziotinib into the first-line treatment of NSCLC with...   

ICON CEO: CROs Must Be Aware Of Threat Posed By Big Tech

ICON’s CEO Steve Cutler talks candidly about the impact of biotech funding, disruptive tech providers, and the constant pressure of...   

Executives On The Move: New CEOs Vaxil Bio and Akero Therapeutics, with Some Big Pharma Execs Joining Smaller Companies

This week’s appointments include a new chief business officer at Sutro Biopharma and a new chief medical officer at Crescendo...   

Health, Beauty And Wellness News: ByOM, Premier, Frutarom, Lactalis

New Chapter founders onto next chapter; French dairy firm acquires African pharma's formula business; 'Earth First' packaging for Premier Protein...   

ASLAN, Sosei Pipeline Assets Hit By Development Delays

Two Asia-based companies disclose delays to important clinical pipeline assets, one in oncology driven by apparent ethnic differences in response...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks